About Novopor Advanced Science Private Limited
Data last updated:
Novopor Advanced Science Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 09 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1996PTC025914. Its GSTIN is 36AABCP7422K1ZA (Telangana). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.39 Cr. It was formerly known as Porus Drugs and Intermediates Private Limited. It is led by directors including Radhesh Welling (Managing Director) and Sameer Sharma.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,314.03 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹156.88 Cr (net margin 11.9%) and EBITDA of ₹246.06 Cr (EBITDA margin 18.7%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
The company has about 638 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Porus Laboratories. As per MCA filings, the company has open charges of ₹1,239.57 Cr and satisfied charges of ₹229.82 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending. The company has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹6.53 Cr; the latest was in March 2024. Its 7 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 5 smaller; the largest is Aquapharm Chemical Limited with revenue of ₹1,431.07 Cr. The company has 2 MSME Form 1 returns on record between 2023 and 2024, listing 12 overdue payments to 11 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website poruslabs.com.
Company details
CIN history
Novopor Advanced Science has one previous CIN (Corporate Identification Number): U24230AP1996PTC025914. The current CIN is U24230TG1996PTC025914, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1996PTC025914 | Current |
| U24230AP1996PTC025914 | Previous |
Contact details
Novopor Advanced Science Private Limited's registered office is in Hyderabad, Telangana. Its website is poruslabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address4th Floor Kkr Square Kavuri Hills, Road No 36 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Novopor Advanced Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Novopor Advanced Science operates one associated brand: Porus Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of API production services | poruslabs.com |
Business activity
The main business activity of Novopor Advanced Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Novopor Advanced Science Private Limited, buy the company report.
Financials of Novopor Advanced Science Private Limited
FY 2025 filings availableNovopor Advanced Science Private Limited reported revenue of ₹1,314.03 Cr (up 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 66% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,314.03 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹246.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹156.88 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.7% | ||||
| Net Profit Margin | 11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novopor Advanced Science Private Limited, buy the company report.
Board of directors and KMP of Novopor Advanced Science Private Limited
Novopor Advanced Science Private Limited currently reports 6 directors and 1 key managerial person. 24 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radhesh Welling | Managing Director | 19 Jan 2024 | 2 Years 9 Months | Current |
| Sameer Sharma Also directs: J. K. Cement Limited., Apitco Foundation | Director | 05 Dec 2024 | 1 Years 11 Months | Current |
| Vipul Shah Also directs: Deepak Nitrite Limited, The Supreme Industries Limited, Vishakha Renewables Limited and 3 more | Director | 06 Sep 2024 | 2 Years 2 Months | Current |
| Saahil Haresh Bhatia | Director | 26 Jun 2025 | 1 Years 4 Months | Current |
| Rishi Mandawat Also directs: Builtsuit DC Park 1 LLP, Dhoot Transmission Limited, Manappuram Finance Limited and 5 more | Director | 18 Sep 2023 | 3 Years 1 Months | Current |
| Geeta Mathur Also directs: Healthcare Global Enterprises Limited, Dixon Technologies (India) Limited, Ashok Leyland Limited and 5 more | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
Peer comparison
Novopor Advanced Science Private Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aquapharm Chemical Limited | ₹1,431.07 Cr (FY 2025) | 491.0% | Pune, Maharashtra, India | |||
| Archean Chemical Industries Limited | ₹1,373.41 Cr (FY 2024) | -7.0% | Chennai, Tamil Nadu, India | |||
| Novopor Advanced Science Private Limitedthis company | ₹1,314.03 Cr (FY 2025) | ₹156.88 Cr | 11.9% | 66.0% | 638 | Hyderabad, Telangana, India |
| Nouryon Chemicals India Private Limited | ₹1,313.63 Cr (FY 2025) | 14.0% | Thane, Maharashtra, India | |||
| Clariant Igl Specialty Chemicals Private Limited | ₹1,302.01 Cr (FY 2025) | 13.0% | Kashipur, Uttarakhand, India | |||
| Grauer and Weil (India) Limited | ₹1,180.04 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Hemani Industries Limited | ₹1,166.06 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Sami-Sabinsa Group Limited | ₹1,137 Cr (FY 2025) | -6.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Novopor Advanced Science Private Limited, buy the company report.
Auditor
Novopor Advanced Science Private Limited is audited by Deloitte Haskins & Sells for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2025 | 008072S |
Shareholding
The shareholding of Novopor Advanced Science Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novopor Advanced Science Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2026 | 101239509 | Axis Bank Limited | ₹86 Cr | Open | |
| 25 Sep 2025 | 101168189 | Citi Bank N.A. | ₹100 Cr | Open | |
| 21 Apr 2025 | 101096138 | Dbs Bank Ltd | ₹320.95 Cr | Open | |
| 20 Jan 2023 | 100678806 | Axis Bank Limited | ₹125 Cr | Open | |
| 24 Sep 2021 | 100501045 | Hdfc Bank Limited | ₹75 Cr | Open |
To see the full charge records of Novopor Advanced Science Private Limited, buy the company report.
Total charge records: 41 View all charges
Deals & funding
Novopor Advanced Science Private Limited has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹6.53 Cr; the latest was in March 2024.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Acquisition | ₹1,710.01 Cr | Buyer: Bain Capital Private Equity Seller: 4 individuals |
| Jul 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Jan 2014 | Funding round | ₹2 Cr | Investors: 4 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Novopor Advanced Science Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Novopor Advanced Science Private Limited has 4 court cases on record: 1 filed by Novopor Advanced Science, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 1 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (COP) | Filed against the company by Enzibeta Biotech Private Limited | Pending |
| High Court for State of Telangana | Arbitration matter | Filed against the company by Enzibeta Biotech Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Court case (COP) | Filed against the company by Enzibeta Biotech Private Limited | Disposed |
| Supreme Court | Court case (9999-Other) | Filed by the company against an individual | Disposed |
To see the full case history of Novopor Advanced Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Novopor Advanced Science Private Limited was last rated by Crisil on 26 Jul 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Jul 2019 |
To see the full credit ratings and regulatory alerts of Novopor Advanced Science Private Limited, buy the company report.
MSME payment delays
Novopor Advanced Science Private Limited has 2 MSME Form 1 returns on record between 2023 and 2024, listing 12 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Mac Labs Limited | |||
| Datar Engineering and Consultancy Private Limited | |||
| Polmon Instruments Private Limited | |||
| Bew Engineering Limited |
To see the full MSME payment records of Novopor Advanced Science Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Novopor Advanced Science Private Limited has a workforce of 638 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
GST
Novopor Advanced Science has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCP7422K1ZA | Telangana | Active | 01 Jul 2017 |
| 36AABCP7422K2Z9 | Telangana | Active | 14 Aug 2017 |
| 37AABCP7422K1Z8 | Andhra Pradesh | Active | 01 Jul 2017 |
| 37AABCP7422K2Z7 | Andhra Pradesh | Active | 23 Sep 2017 |
To see the full GST registrations and return filing status of Novopor Advanced Science Private Limited, buy the company report.
Recent activity
Novopor Advanced Science Private Limited has 30 board changes on record since 2019: 9 appointments and 21 cessations. The latest: Rajendra Kumar Sahu was appointed as CEO on 11 Nov 2025.
106 earlier events are in the company report.
News
Frequently asked questions
Novopor Advanced Science is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 09 December 1996 (30+ years old) and is registered under CIN U24230TG1996PTC025914.
Novopor Advanced Science has 7 current directors and KMP:
- Radhesh Welling - Managing Director
- Sameer Sharma - Director
- Vipul Shah - Director
- Saahil Haresh Bhatia - Director
- Rishi Mandawat - Director
- Geeta Mathur - Director
- Rajendra Kumar Sahu - Ceo
The latest financial statements of Novopor Advanced Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Novopor Advanced Science is 36AABCP7422K1ZA, registered in Telangana. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 36AABCP7422K2Z9 (Telangana), 37AABCP7422K1Z8 (Andhra Pradesh), 37AABCP7422K2Z7 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Novopor Advanced Science is U24230TG1996PTC025914. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novopor Advanced Science has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Novopor Advanced Science was incorporated on 09 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
Novopor Advanced Science has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹6.53 Cr; the latest was in March 2024.
The peers of Novopor Advanced Science by revenue are Aquapharm Chemical Limited, Archean Chemical Industries Limited, Nouryon Chemicals India Private Limited, Clariant Igl Specialty Chemicals Private Limited, Grauer and Weil (India) Limited and 2 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajendra Kumar Sahu was appointed as CEO on 11 Nov 2025. Rajendra Kumar Sahu ceased to be Additional Director on 11 Nov 2025. Sanjib Nanda ceased to be CFO on 30 Sep 2025. Novopor Advanced Science has 30 board changes on record in total.
Novopor Advanced Science has 2 MSME Form 1 returns on record between 2023 and 2024, listing 12 overdue payments to 11 micro and small suppliers. The latest return was filed on 20 Apr 2024.
Novopor Advanced Science can be reached through the website poruslabs.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
